 |
ANA InvestigatesAuthor: American Neurological Association
At a time when support for basic and translational science needs a strong voice and the burden of neurological disease is growing, the ANA is the champion of neurological research and the ally of all physicians and scientists who strive to make a difference through careers that combine discovery, education, and clinical care. From advances in stroke and dementia to movement disorders and epilepsy, the American Neurological Association has been at the forefront of research and practice since 1875 as the premier professional society of academic neurologists and neuroscientists devoted to understanding and treating diseases of the nervous system. Language: en Genres: Health & Fitness, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it Trailer: |
Listen Now...
ANA investigates Mechanical Thrombectomy for Medium Vessel Occlusions
Episode 11
Tuesday, 11 August, 2026
In this episode, we are discussing one of the most rapidly evolving areas in acute stroke care, mechanical thrombectomy for medium vessel occlusions, or MEVO. While thrombectomy is well established for large vessel occlusions, whether patients with smaller, more distal occlusions benefit has remained an important unanswered question. In the recent years, several landmark trials have evaluated endovascular treatment for MEVO with differing results, some suggesting benefits while others suggesting no benefit. Together, these studies have shifted the conversation from whether thrombectomy should be performed to which patients are most likely to benefit. To discuss how these findings are reshaping clinical practice and the future of thrombectomy stroke trials, we spoke with Dr. Mayank Goyal, professor of radiology and clinical neurosciences at the University of Calgary. He was interviewed by Dr. Omar Al-Janabi, a stroke neurologist at Baptist Health. Disclosures: Dr. Goyal discloses consulting fees from Medtronic, Penumbra, Jacob's Institute, Silvercreek Pharma, Microvention, and grant funding from Medtronic and Cerenovus
